XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activities

The activity for stock options is as follows:

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contract Terms
(in years)

 

 

Aggregate
Intrinsic
Values
(in thousands)

 

Balance as of December 31, 2021

 

 

2,922,135

 

 

$

3.62

 

 

 

9.14

 

 

$

21,144

 

Options granted

 

 

1,673,932

 

 

 

7.80

 

 

 

 

 

 

 

Options cancelled and forfeited

 

 

(62,646

)

 

 

4.18

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of September 30, 2022

 

 

4,533,421

 

 

$

5.16

 

 

 

8.71

 

 

$

4,285

 

Vested and expected to vest, September 30, 2022(1)

 

 

4,488,421

 

 

$

5.13

 

 

 

8.71

 

 

$

4,285

 

Options exercisable as of September 30, 2022

 

 

1,499,959

 

 

$

3.25

 

 

 

8.27

 

 

$

2,338

 

Summary of Assumptions Used in Black-Scholes Model

The fair value of the Company’s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the nine months ended September 30, 2022:

 

Expected term (in years)

 

5.50 - 6.50

Expected volatility

 

77.33% - 80.54%

Risk-free interest rate

 

1.69% - 3.03%

Expected dividend yield

 

0.00%

Summary of Restricted Stock Awards

The activity for restricted stock awards is as follows:

 

 

 

Number of Shares

 

 

Weighted-Average
Grant Date Fair Value

 

Unvested at December 31, 2021(1)

 

 

332,364

 

 

$

7.30

 

Granted

 

 

 

 

 

 

Vested

 

 

(113,054

)

 

 

7.95

 

Forfeited

 

 

 

 

 

 

Unvested at September 30, 2022

 

 

219,310

 

 

$

7.46

 

Summary of Share-based Compensation Expense

The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company’s condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development expense

 

$

657

 

 

$

297

 

 

$

1,872

 

 

$

626

 

General and administrative expense

 

 

1,126

 

 

 

939

 

 

 

3,224

 

 

 

1,957

 

Total stock-based compensation expense

 

$

1,783

 

 

$

1,236

 

 

$

5,096

 

 

$

2,583